Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.58 AUD
Change Today 0.00 / 0.00%
Volume 254.9K
As of 2:10 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

acrux ltd (ACR) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/19/15 - A$1.65
52 Week Low
09/30/15 - A$0.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ACRUX LTD (ACR)

Related News

No related news articles were found.

acrux ltd (ACR) Related Businessweek News

No Related Businessweek News Found

acrux ltd (ACR) Details

Acrux Limited is engaged in the development and commercialization of healthcare products in Australia, Switzerland, the United States, and internationally. Its marketed products comprise Axiron for the treatment of testosterone deficiency in men; Recuvyra for pain relief of dogs; and Evamist for menopausal symptoms. The company’s product under registration study includes Estradiol MDTS for menopausal symptoms. It is also developing products, which are in formulation stage for the treatment of non-melanoma skin cancer, anti-fungal, pain and inflammation, and other diseases, as well as developing product for the treatment of animal health. The company was founded in 1998 and is headquartered in West Melbourne, Australia.

Founded in 1998

acrux ltd (ACR) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$322.8K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$186.2K
Product Development and Technical Affairs Dir...
Total Annual Compensation: A$186.9K
Commercial Director
Total Annual Compensation: A$134.4K
Compensation as of Fiscal Year 2015.

acrux ltd (ACR) Key Developments

Acrux Limited to Report Fiscal Year 2015 Results on Aug 13, 2015

Acrux Limited announced that they will report fiscal year 2015 results on Aug 13, 2015

Acrux Limited Announces Audited Consolidated Earnings Results for the Year Ended June 30, 2015

Acrux Limited announced audited consolidated earnings results for the year ended June 30, 2015. For the year, the company reported revenue of SGD 25,368,000 against SGD 53,859,000 a year ago. Profit before income tax was SGD 16,806,000 against SGD 43,857,000 a year ago. Profit for the year was SGD 11,130,000 against SGD 27,970,000 a year ago. Basic and diluted earnings per share were 6.70 cents against 16.80 cents a year ago. Net cash flows provided by operating activities were SGD 10,519,000 against SGD 36,371,000 a year ago. Purchase of plant and equipment was SGD 66,000 against SGD 39,000 a year ago.

Acrux Limited Declares Final Dividend, Payable on 3 September 2015

Acrux Limited declared final dividend of 6 cents per share, fully franked, expected payment date on 3 September 2015. Record date is on 20 August 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACR:AU A$0.58 AUD 0.00

ACR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Austin Engineering Ltd A$0.38 AUD 0.00
Bradken Ltd A$1.06 AUD -0.025
Emeco Holdings Ltd A$0.06 AUD -0.001
Endo International PLC $71.06 USD +1.04
Seven Group Holdings Ltd A$4.36 AUD -0.03
View Industry Companies

Industry Analysis


Industry Average

Valuation ACR Industry Range
Price/Earnings 7.9x
Price/Sales 3.3x
Price/Book 2.2x
Price/Cash Flow 7.0x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACRUX LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at